Predicting the risk of recurrent venous thromboembolism (VTE)

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


To optimize patient outcomes with anticoagulation for venous thromboembolism (VTE), it is essential to assess patients for their recurrence risk. In this article, I will review the impact of clinical and laboratory risk factors for recurrent VTE. The presence or absence of VTE risk factors at the time of the index thrombotic event provides important information regarding recurrence risk. Patients with potent situational risk factors for thrombosis (e.g., surgery) are at low risk for recurrence while patients suffering unprovoked events are at high risk for recurrence. The presence of non-surgical clinical risk factors place patients at intermediate recurrence risk. Other clinical risk factors of variable recurrence potential include age, sex, cancer, pregnancy/puerperium, hormonal therapy and obesity. Laboratory risk factors for recurrence include thrombophilia, D dimer and other global coagulation assays as well as residual venous obstruction. Several multivariate VTE risk assessment models have been developed that combine clinical and laboratory risk factors of recurrence. If validated, these risk scores may allow for personalized anticoagulation therapy tailored to patients’ individual recurrence risk.

Original languageEnglish (US)
Pages (from-to)353-366
Number of pages14
JournalJournal of Thrombosis and Thrombolysis
Issue number3
StatePublished - Apr 2015


  • D dimer
  • Recurrence
  • Risk assessment models
  • Risk factors
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Predicting the risk of recurrent venous thromboembolism (VTE)'. Together they form a unique fingerprint.

Cite this